In today’s recent session, 1.61 million shares of the Guardant Health Inc (NASDAQ:GH) have been traded, and its beta is 1.11. Most recently the company’s share price was $25.78, and it changed around -$3.24 or -11.16% from the last close, which brings the market valuation of the company to $3.17B. GH at last check was trading at a discount to its 52-week high of $41.06, offering almost -59.27% off that amount. The share price’s 52-week low was $15.81, which indicates that the recent value has risen by an impressive 38.67% since then. We note from Guardant Health Inc’s average daily trading volume that its 10-day average is 2.01 million shares, with the 3-month average coming to 2.15 million.
Guardant Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.29. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended GH as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Guardant Health Inc is expected to report earnings per share of -0.76 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH has been showing red trend so far today with a performance of -11.16% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 29.26 on recent trading dayincreased the stock’s daily price by 11.89%. The company’s shares are currently down -4.70% year-to-date, but still down -9.16% over the last five days. On the other hand, Guardant Health Inc (NASDAQ:GH) is -21.88% down in the 30-day period. We can see from the shorts that 6.99 million shares have been sold at a short interest cover period of 4.27 day(s).
The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to increase their stock price by 35.55% from its current value. Analyst projections state that GH is forecast to be at a low of $36 and a high of $125.
Guardant Health Inc (GH) estimates and forecasts
Guardant Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 32.75 percent over the past six months and at a 52.57% annual growth rate that is well above the industry average of 18.30%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -4.10% in revenue this quarter, and will report an increase of 54.40% in the next quarter. The year-over-year growth rate is expected to be 23.30%, up from the previous year.
Consensus estimates provided by 20 financial analysts predict the company will bring in an average of 170.65M in revenue for the current quarter. 20 analysts expect Guardant Health Inc to make 180.55M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 143.03M and 155.05M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 19.30%. Forecasts for the next quarter put sales growth at 16.40%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.88%. Guardant Health Inc earnings are expected to increase by 23.74% in 2024, but the outlook is positive 29.20% per year for the next five years.
GH Dividends
Guardant Health Inc’s next quarterly earnings report is expected to be released on 2024-Nov-04.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.56% of Guardant Health Inc shares, and 97.00% of them are in the hands of institutional investors. The stock currently has a share float of 101.64%. Guardant Health Inc stock is held by 402.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.5609% of the shares, which is about 11.64 million shares worth $336.07 million.
BLACKROCK INC., with 9.2332% or 11.24 million shares worth $324.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard U.S. Growth Fund were the top two Mutual Funds as of Mar 31, 2024. The former held 3.53 shares worth $91.37 million, making up 2.87% of all outstanding shares. On the other hand, Vanguard U.S. Growth Fund held roughly 3.14 shares worth around $81.3 million, which represents about 2.55% of the total shares outstanding.
